Given the lack of treatments for diabetic neuropathy (DN), a common diabetic complication, accurate disease models are necessary. Characterization of the leptin-deficient BTBR ob/ob mouse, a type 2 diabetes model, demonstrated that the mice develop robust diabetes coincident with severe neuropathic features, including nerve conduction deficits and intraepidermal nerve fiber loss by 9 and 13 weeks of age, respectively, supporting its use as a DN model. To gain insight into DN mechanisms, we performed microarray analysis on sciatic nerve from BTBR ob/ob mice, identifying 1503 and 642 differentially expressed genes associated with diabetes at 5 and 13 weeks, respectively. Further analyses identified overrepresentation of inflammation and immunerelated functions in BTBR ob/ob mice, which interestingly were more highly represented at 5 weeks, an observation that may suggest a contributory role in DN onset. To complement the gene expression analysis, we demonstrated that protein levels of select cytokines were significantly upregulated at 13 weeks in BTBR ob/ob mouse sciatic nerve. Furthermore, we compared our array data to that from an established DN model, the C57BKS db/ db mouse, which reflected a common dysregulation of inflammatory and immune-related pathways. Together, our data demonstrate that BTBR ob/ob mice develop rapid and robust DN associated with dysregulated inflammation and immune-related processes.
Introduction
Type 2 diabetes (T2D) has reached epidemic proportions worldwide, affecting over 382 million individuals (International Diabetes Federation, 2013) . The associated hyperglycemia, insulin resistance, and/or obesity lead to microvascular complications that impact multiple organs and tissues, including the eyes, kidney, and peripheral nerves. Peripheral diabetic neuropathy (DN), the most common microvascular complication (Centers for Disease Control, Prevention, 2011), is characterized by distal-to-proximal nerve damage that promotes pain and loss of sensation. Sensory deficits combined with poor wound healing can trigger foot ulcer development and non-traumatic lower limb amputations, contributing to the severe morbidity of DN (Malik et al., 2013) .
Although the exact etiology remains unclear, the consensus is that DN results from metabolic and physiological imbalances within the peripheral nerve. Persistent hyperglycemia-induced oxidative stress promotes nerve damage (Vincent et al., 2011; Fernyhough et al., 2010) , and evidence also suggests that dyslipidemia contributes to aberrant nerve function (Wiggin et al., 2009; Vincent et al., 2009 ). Numerous biochemical processes, including the formation of advanced glycation end products, increased NADPH oxidase activity, activation of poly-ADP ribose polymerase, and inflammation, are implicated in DN (Vincent et al., 2011; O'Brien et al., 2014a; Wilson and Wright, 2011) . Thus, elucidating the precise mechanisms underlying nerve injury is of paramount importance to develop successful therapies.
Various mouse models exist that mimic a diabetes-like phenotype and exhibit key DN features (O'Brien et al., 2014b) ; however, additional models that accurately recapitulate the complex pathogenesis of T2D are required to gain insight into DN etiology and support translational studies. The leptin-deficient BTBR ob/ob mouse is a robust model of T2D (Clee et al., 2005; Coppari and Bjorbaek, 2012) ; they are hyperphagic and present with early obesity, insulin resistance, and hyperglycemia at a severity greater than that observed in C57BL6 ob/ob mice (Clee et al., 2005; Hudkins et al., 2010; Keller et al., 2008) . Additionally, these mice develop renal complications closely mimicking human diabetic nephropathy, evidenced by glomerular hypertrophy, capillary basement membrane thickening, and loss of podocytes (Hudkins et al., 2010) . The effects on the peripheral nerve in this model, however, have not been characterized.
In the current study, the primary objective was to characterize the neurological phenotype in BTBR ob/ob mice. We confirm that BTBR ob/ob mice present with robust features of T2D and exhibit an early Neurobiology of Disease 73 (2015) 348-355 
